| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute and Long-Term Toxicities Associated with Gemtuzumab Ozogamicin (Mylotarg®) Therapy of Acute Myeloid Leukemia
|
Leopold, Lance H.
|
|
2002
|
|
S1 |
p. S29-S34
6 p.
|
artikel
|
| 2 |
An Oncologist's Approach to Therapy for Cutaneous T-Cell Lymphoma
|
Foss, Francine M.
|
|
2000
|
|
S1 |
p. S9-S14
6 p.
|
artikel
|
| 3 |
Antibody Therapy in Acute Myeloid Leukemia: Current Status and Future Directions
|
Burke, John M.
|
|
2002
|
|
S1 |
p. S12-S18
7 p.
|
artikel
|
| 4 |
Bexarotene and DAB389IL-2 (Denileukin Diftitox, ONTAK) in Treatment of Cutaneous T-Cell Lymphomas: Algorithms
|
Duvic, Madeleine
|
|
2000
|
|
S1 |
p. S51-S55
5 p.
|
artikel
|
| 5 |
CD33 as a Target for Selective Ablation of Acute Myeloid Leukemia
|
Bernstein, Irwin D.
|
|
2002
|
|
S1 |
p. S9-S11
3 p.
|
artikel
|
| 6 |
Challenges in the Management of Burkitt's Lymphoma
|
Levine, Alexandra M.
|
|
2002
|
|
S1 |
p. S19-S25
7 p.
|
artikel
|
| 7 |
Combining Yttrium 90–Labeled Ibritumomab Tiuxetan with High-Dose Chemotherapy and Stem Cell Support in Patients with Relapsed Non-Hodgkin's Lymphoma
|
Winter, Jane N.
|
|
2004
|
|
S1 |
p. S22-S26
5 p.
|
artikel
|
| 8 |
Cutaneous T-Cell Lymphomas: Prognosis and Quality-of-Life Issues
|
Dummer, Reinhard
|
|
2000
|
|
S1 |
p. S21-S25
5 p.
|
artikel
|
| 9 |
DAB389IL-2 (Denileukin Diftitox, ONTAK): A New Fusion Protein Technology
|
Foss, Francine M.
|
|
2000
|
|
S1 |
p. S27-S31
5 p.
|
artikel
|
| 10 |
DAB389IL-2 (Denileukin Diftitox, ONTAK): Other Potential Applications
|
LeMaistre, C. Frederick
|
|
2000
|
|
S1 |
p. S37-S40
4 p.
|
artikel
|
| 11 |
DAB389IL-2 (Denileukin Diftitox, ONTAK): Review of Clinical Trials to Date
|
Kuzel, Timothy M.
|
|
2000
|
|
S1 |
p. S33-S36
4 p.
|
artikel
|
| 12 |
Early Phase I/II Trials with Gemtuzumab Ozogamicin (Mylotarg®) in Acute Myeloid Leukemia
|
Nabhan, Chadi
|
|
2002
|
|
S1 |
p. S19-S23
5 p.
|
artikel
|
| 13 |
Epoetin Alfa Therapy for Patients with Hematologic Malignancies and Mild Anemia
|
Straus, David J.
|
|
2003
|
|
S1 |
p. S13-S17
5 p.
|
artikel
|
| 14 |
Factors Associated with Toxicity and Response to Yttrium 90–Labeled Ibritumomab Tiuxetan in Patients with Indolent Non-Hodgkin's Lymphoma
|
Borghaei, Hossein
|
|
2004
|
|
S1 |
p. S16-S21
6 p.
|
artikel
|
| 15 |
Farnesyltransferase Inhibitors in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|
Cortes, Jorge
|
|
2003
|
|
S1 |
p. S30-S35
6 p.
|
artikel
|
| 16 |
Historical Perspective on the Use of Retinoids in Cutaneous T-Cell Lymphoma(CTCL)
|
Burg, Günter
|
|
2000
|
|
S1 |
p. S41-S44
4 p.
|
artikel
|
| 17 |
Introduction
|
Jain, Vinay K.
|
|
2003
|
|
S1 |
p. S4-
1 p.
|
artikel
|
| 18 |
Introduction
|
Tallman, Martin S.
|
|
2002
|
|
S1 |
p. S7-
1 p.
|
artikel
|
| 19 |
Introduction
|
Armitage, James O.
|
|
2002
|
|
S1 |
p. S4-
1 p.
|
artikel
|
| 20 |
Management of Hepatic Sinusoidal Obstruction Syndrome Following Treatment with Gemtuzumab Ozogamicin (Mylotarg®)
|
McDonald, George B.
|
|
2002
|
|
S1 |
p. S35-S39
5 p.
|
artikel
|
| 21 |
Metabolic Abnormalities in Lymphoma
|
Cabanillas, Fernando
|
|
2002
|
|
S1 |
p. S32-S36
5 p.
|
artikel
|
| 22 |
New Directions in Radioimmunotherapy of Non-Hodgkin's Lymphoma
|
DeNardo, Gerald L.
|
|
2004
|
|
S1 |
p. S4-
1 p.
|
artikel
|
| 23 |
Ongoing Trials with Yttrium 90–Labeled Ibritumomab Tiuxetan in Patients with Non-Hodgkin's Lymphoma
|
Micallef, Ivana N.M.
|
|
2004
|
|
S1 |
p. S27-S32
6 p.
|
artikel
|
| 24 |
Overview of Antibody Therapy in B-Cell Non-Hodgkin's Lymphoma
|
Wannesson, Luciano
|
|
2003
|
|
S1 |
p. S5-S12
8 p.
|
artikel
|
| 25 |
Overview of Rational and Individualized Therapeutic Strategies for Non-Hodgkin's Lymphomas
|
Armitage, James O.
|
|
2002
|
|
S1 |
p. S5-S11
7 p.
|
artikel
|
| 26 |
Pegylated Liposomal Doxorubicin, Vincristine, and Reduced-Dose Dexamethasone as First-Line Therapy for Multiple Myeloma
|
Hussein, Mohamad
|
|
2003
|
|
S1 |
p. S18-S22
5 p.
|
artikel
|
| 27 |
Prevention and Treatment of Hyperuricemia in Hematological Malignancies
|
Cairo, Mitchell S.
|
|
2002
|
|
S1 |
p. S26-S31
6 p.
|
artikel
|
| 28 |
Radioimmunotherapy in Non-Hodgkin's Lymphoma: Trials of Yttrium 90–Labeled Ibritumomab Tiuxetan and Beyond
|
Evens, Andrew M.
|
|
2004
|
|
S1 |
p. S11-S15
5 p.
|
artikel
|
| 29 |
Radiometals as Payloads for Radioimmunotherapy for Lymphoma Lymphoma
|
DeNardo, Gerald L.
|
|
2004
|
|
S1 |
p. S5-S10
6 p.
|
artikel
|
| 30 |
The Implications of Anemia in Multiple Myeloma
|
Mittelman, Moshe
|
|
2003
|
|
S1 |
p. S23-S29
7 p.
|
artikel
|
| 31 |
The Role of Erythropoietin in the Anemia of Myelodysplastic Syndrome
|
Stein, Richard S.
|
|
2003
|
|
S1 |
p. S36-S40
5 p.
|
artikel
|
| 32 |
The Treatment of Cutaneous T-Cell Lymphoma with a Novel Retinoid
|
Heald, Peter
|
|
2000
|
|
S1 |
p. S45-S49
5 p.
|
artikel
|
| 33 |
Treatment of Cutaneous T-Cell Lymphoma from a Dermatologist's Perspective
|
Duvic, Madeleine
|
|
2000
|
|
S1 |
p. S15-S20
6 p.
|
artikel
|
| 34 |
Treatment Paradigms in Aggressive Non-Hodgkin's Lymphoma in Elderly Patients
|
Coiffier, Bertrand
|
|
2002
|
|
S1 |
p. S12-S18
7 p.
|
artikel
|
| 35 |
Trials with Gemtuzumab Ozogamicin (Mylotarg®) Combined with Chemotherapy Regimens in Acute Myeloid Leukemia
|
Stadtmauer, Edward A.
|
|
2002
|
|
S1 |
p. S24-S28
5 p.
|
artikel
|
| 36 |
Two Novel Therapies for the Treatment of Cutaneous T-Cell Lymphoma
|
LeMaistre, C. Frederick
|
|
2000
|
|
S1 |
p. S7-
1 p.
|
artikel
|
Tijdschrift beschrijving